Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a t-cell infiltrate in the bone marrow

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)e270-e273
JournalHaematologica
Volume103
Issue number6
DOIs
StatePublished - Jun 3 2018

Cite this